The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Scoring schemes for the assessment of skin and keel bone status in laying hens¹ [29]. by Lisa Jung (13264758)

Antibiotic use in small animals by substance registration status. by Sarin Suwanpakdee (119683)

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... by Takafira Mduluza (39754)

Descriptive statistics (means) for full sample and by lockdown status. by Drew B. Cameron (10687420)

Perioperative IL-6 and sIL-6r dynamics according to rs2069845 allele status. by Kyle D. Anderson (2296873)

A deidentified raw data set is attached to this manuscript, providing soluble IL-6 and sIL-6r levels, as well as SNP allele statuses. by Kyle D. Anderson (2296873)

Mean scores and 95% CIs according to SARS-CoV-2 infection status and work-related determinants. by A. H. Ayesha Lavell (16734002)

Mental health status of respondents (n = 259). by Isha Aryal (22582068)

Characteristics of the investigated laying hen flocks with numbers of assessed hens on-farm concerning skin and keel bone status. by Lisa Jung (13264758)

Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

Cohort characteristics. by Vincent Pey (21433304)

“…The measurement of arterial whole blood redox potential (E_redox) provides a systemic assessment of the redox state and may serve as a valuable marker for detecting metabolic perturbations during CPB. …”

Relationship of risk score with immune status. by Yajia Chen (20685780)

Supplementary Material for: The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient by Hiraoka A. (4273894)

“…Since immune therapy shows a favorable therapeutic efficacy, use of tumor markers as biomarkers for monitoring treatment response is necessary. …”

Mean probability of reporting a specific health status in non-hypertensive and hypertensive patients, with and without related medication, while excluding the effects of other fact... by Jesús Martín-Fernández (406234)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)